5RU-11479-55812
3 vaccinations
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 104 / NY
- Registered
- 2021-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-04-06
Dose 1 — Pfizer-BioNTech
-
2021-04-27
Dose 2 — Pfizer-BioNTech
-
2021-12-11
Dose 3 — Pfizer-BioNTech
-
2021-12-20
Registered in v-safe
- 2021-12-20
- 2021-12-25
- 2022-01-01
- 2022-01-08
- 2022-01-17
- 2022-01-22
- 2022-03-12
-
2022-06-16
Survey response — 6 months, dose 3MedDRA: Influenza like illness — Feeling: GoodFree text: Flu-like symtomps. I tested negative on antigen test but my family tested positiveMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-06 | Pfizer-BioNTech | No |
| 2 | 2021-04-27 | Pfizer-BioNTech | No |
| 3 | 2021-12-11 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3
Symptoms: Flu-like symtomps. I tested negative on antigen test but my family tested positive
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza like illness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release